https://www.investors.com/research/ibd-stock-of-the-day/eli-lilly-stock-is-nearing-a-record-again-as-it-enters-the-weight-loss-drugs-arena/
0
0
11/20/23 at 11:41am
Organization
Investor's Business Daily
Author
Investor's Business Daily
37 words
0
Comments
The FDA recently approved Eli Lilly's weight-loss drug, Zepbound, a rival to Novo Nordisk's Wegovy.
You are the first to view
Create an account
or login to join the discussion